Atlas Trials

Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS)

Clinical trial NCT04937907 · COMPLETED

Trial details

NCT number
NCT04937907
Sponsor
Shanghai Children's Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alport Syndrome, X-Linked
Start date
2021-09-08
Primary completion
2024-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.